Tashkova D, Ilieva N, Serteva D, Feodorova Y, Mehterov N, Mollova A, Bachurska S. Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status.
Folia Med (Plovdiv) 2023;
65:378-383. [PMID:
38351812 DOI:
10.3897/folmed.65.e81334]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Accepted: 04/27/2022] [Indexed: 02/16/2024] Open
Abstract
INTRODUCTION
Aberrant expression of CK7/CK20/CDX2 is reported in percentage of colorectal carcinomas (CRC).
Collapse